Total lesion glycolysis of primary tumor and lymphnodes is a strong predictor for development of distant metastases in oropharyngeal carcinoma patients with independent validation in automatically delineated lesions

Publikation: Beitrag in Fachzeitschrift › Forschungsartikel › Beigetragen › Begutachtung

Beitragende

  • Sebastian Zschaeck - , Berliner Institut für Gesundheitsforschung in der Charité, Universitätsklinikum Carl Gustav Carus Dresden, Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • Marina Hajiyianni - , Berliner Institut für Gesundheitsforschung in der Charité (Autor:in)
  • Patrick Hausmann - , Berliner Institut für Gesundheitsforschung in der Charité (Autor:in)
  • Pavel Nikulin - , Helmholtz-Zentrum Dresden-Rossendorf (HZDR) (Autor:in)
  • Emily Kukuk - , Berliner Institut für Gesundheitsforschung in der Charité (Autor:in)
  • Christian Furth - , Berliner Institut für Gesundheitsforschung in der Charité (Autor:in)
  • Paulina Cegla - , Wielkopolskie Centrum Onkologii (Autor:in)
  • Elia Lombardo - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Joanna Kazmierska - , University of Medical Sciences Poznan, Wielkopolskie Centrum Onkologii (Autor:in)
  • Adrien Holzgreve - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Iosif Strouthos - , European University Cyprus (Autor:in)
  • Carmen Stromberger - , Berliner Institut für Gesundheitsforschung in der Charité (Autor:in)
  • Claus Belka - , Ludwig-Maximilians-Universität München (LMU), Bayerisches Zentrum für Krebsforschung (BZKF) (Autor:in)
  • Michael Baumann - , Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Carl Gustav Carus Dresden, Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • Mechthild Krause - , Klinik und Poliklinik für Strahlentherapie und Radioonkologie, OncoRay - Nationales Zentrum für Strahlenforschung in der Onkologie, Universitätsklinikum Carl Gustav Carus Dresden, Deutsches Konsortium für Translationale Krebsforschung (DKTK) - Dresden, Deutsches Krebsforschungszentrum (DKFZ), Deutsches Konsortium für Translationale Krebsforschung (DKTK) - München, Helmholtz-Zentrum Dresden-Rossendorf (HZDR) (Autor:in)
  • Guillaume Landry - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Witold Cholewinski - , Wielkopolskie Centrum Onkologii, University of Medical Sciences Poznan (Autor:in)
  • Jorg Kotzerke - , Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Daniel Zips - , Charité – Universitätsmedizin Berlin, Deutsches Konsortium für Translationale Krebsforschung (DKTK) - Berlin, Nationales Zentrum für Tumorerkrankungen (NCT) Berlin, Berliner Institut für Gesundheitsforschung in der Charité, Max-Delbrück-Centrum für Molekulare Medizin (MDC) (Autor:in)
  • Jörg van den Hoff - , Helmholtz-Zentrum Dresden-Rossendorf (HZDR) (Autor:in)
  • Frank Hofheinz - , Helmholtz-Zentrum Dresden-Rossendorf (HZDR) (Autor:in)

Abstract

Background: Oropharyngeal carcinomas are characterized by an increasing incidence and a relatively good prognosis. Nonetheless, a considerable number of patients develops metachronous distant metastases; identification of these patients is an urgent medical need. Methods: This is a retrospective multicenter evaluation of 431 patients. All patients underwent [18F]-FDG positron emission tomography (PET). The cohort was split into an explorative group (n = 366) and a validation group (n = 65). Lesions were manually delineated in the explorative group and automatically delineated by a convolutional neuronal network (CNN) in the validation group. Quantitative PET parameters standardized uptake value (SUV), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were calculated for primary tumors (prim) and tumor plus lymphnodes (all). Association of parameters with freedom from distant metastases (FFDM) and overall survival (OS) was tested by cox regression analyses. Results: In the explorative group, univariate analyses revealed an association of metric MTVprim (p = 0.022), MTVall (p < 0.001) and TLGall (p < 0.001) with FFDM, binarized parameters were also associated with FFDM (p < 0.001 and p = 0.002). Bootstrap analyses revealed a significantly better association of TLGall compared to TLGprim with FFDM (p = 0.02). MTVall and TLGall remained significantly associated with FFDM upon multivariate testing (p = 0.002, p = 0.031, respectively). In the validation group, the cutoff value for TLGall but not for TLGprim was significantly associated with FFDM (HR = 3.1, p = 0.045). Additional analyses with manually delineated contours of the validation cohort revealed a similar effect (HR = 3.47, p = 0.026). No considerable differences between HPV positive and negative disease were observed. Conclusions: TLGall is a promising biomarker to select OPC patients with high risk for metachronous distant metastases.

Details

OriginalspracheEnglisch
Aufsatznummer18
FachzeitschriftCancer Imaging
Jahrgang25
Ausgabenummer1
PublikationsstatusVeröffentlicht - 21 Feb. 2025
Peer-Review-StatusJa

Externe IDs

PubMed 39985091
ORCID /0000-0003-1776-9556/work/199962714

Schlagworte

Ziele für nachhaltige Entwicklung

ASJC Scopus Sachgebiete

  • Radiologie- und Ultraschalltechnik - Fluorodeoxyglucose positron emission tomography, Head and neck squamous cell carcinoma, Oropharynx cancer, Total lesion glycolysis
  • Onkologie - Fluorodeoxyglucose positron emission tomography, Head and neck squamous cell carcinoma, Oropharynx cancer, Total lesion glycolysis
  • Radiologie, Nuklearmedizin und Bildgebung - Fluorodeoxyglucose positron emission tomography, Head and neck squamous cell carcinoma, Oropharynx cancer, Total lesion glycolysis

Schlagwörter

  • Fluorodeoxyglucose positron emission tomography, Head and neck squamous cell carcinoma, Oropharynx cancer, Total lesion glycolysis